Chronic dialysis, NAT2 polymorphisms, and the risk of isoniazid-induced encephalopathy – case report and literature review-Reference-Cited by-同舟云学术

Chronic dialysis, NAT2 polymorphisms, and the risk of isoniazid-induced encephalopathy – case report and literature review

Published:2017-09-04 Issue:1 Volume:18 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Constantinescu Stefan Matei,Buysschaert Benoit,Haufroid Vincent,Broly Franck,Jadoul Michel,Morelle Johann^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1186/s12882-017-0703-6.pdf

Reference13 articles.

1. World Health Organization. Global Tuberculosis Report 20th Edition; 2015.

2. Adams P, White C. Isoniazid-induced encephalopathy. Lancet. 1965;1:680–2.

3. Miscoria G, Leneveu A, Walle C, et al. Application of a method of analysis using high performance liquid chromatography of isoniazid and acetylisoniazid to determine the phenotype of acetylation. Ann Biol Clin (Paris). 1988;46:734–40.

4. Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975–82.

5. Korzets A, Gafter U. Tuberculosis prophylaxis for the chronically dialysed patient - yes or no? Nephrol Dial Transplant. 1999;14:2857–9.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Polymorphisms and Toxicities of First-Line Antituberculosis Drugs: Systematic Review of the Literature;Journal of Tuberculosis Research;2022

2. Extracorporeal treatments for isoniazid poisoning: Systematic review and recommendations from the EXTRIP workgroup;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-04-03

3. Isoniazid-induced Encephalopathy in a Chronic Kidney Disease Patient: A Case Report;Bengal Physician Journal;2020

4. Relationship between NAT2 polymorphisms and onset risk of acute leukemia: a systematic review and meta-analysis;EUR REV MED PHARMACO;2019

5. Isoniazid;Reactions Weekly;2017-09